BCC - Basal Cell Carcinoma
7
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 7 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (7)
Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma
The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes
Effectiveness and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
L19IL2/L19TNF in Skin Cancer Patients
CellFX Treat & Resect Low-Risk BCC Feasibility Study
Laser Immunotherapy With and Without Topical Anti-PD1 in Basal Cell Carcinomas